Digital Twins

SOPHiA GENETICS has launched SOPHiA DDM™ Digital Twins, an AI-powered research technology designed to revolutionize oncology. By creating virtual representations of individual patients using comprehensive data, Digital Twins simulate treatment outcomes, enabling oncologists to make more informed decisions. This allows for in silico experimentation, predicting disease progression and personalizing treatment strategies. The platform leverages a global network of patient data to provide data-driven insights. Initially for lung cancer, expansion to other cancer types is planned, marking a shift towards AI-guided precision medicine.